As of 2025-06-30, the Relative Valuation of Oncternal Therapeutics Inc (ONCT) is (236.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.53 USD, the upside of Oncternal Therapeutics Inc based on Relative Valuation is -45017.4%.
The range of the Relative Valuation is (192.50) - (263.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 22.6x | 18.8x |
| Forward P/E multiples | 16.5x - 26.9x | 21.7x |
| Fair Price | (192.50) - (263.75) | (236.54) |
| Upside | -36655.0% - -50185.7% | -45017.4% |
| Date | P/E |